DC4108Sitaxentan sodium
Sitaxsentan (sodium) is an orally active, highly selective antagonist of endothelin A receptors.
View activity & prices5 products · Page 1 of 1
All small molecule research tools
DC4108Sitaxsentan (sodium) is an orally active, highly selective antagonist of endothelin A receptors.
View activity & prices
DC8191Sparsentan (RE-021; BMS-346567; PS433540; DARA-a) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively.
View activity & prices
DC11513ACT-132577 is the major and pharmacologically active metabolite of macitentan, which is dual ETA/ETB antagonist designed for tissue targeting.
View activity & prices
DC8392BQ-123 is an ETA endothelin receptor antagonist (Ki values are 1.4 and 1500 nM at ETA and ETB receptors respectively) . 1) Reduces ischemia-induced ventricular arrhythmias in a rat model.2) BQ-123 prevents LPS-induced…
View activity & prices
DC1012Macitentan is an orally active, non-peptide endothelin receptor antagonist for the treatment of idiopathic pulmonary fibrosis and pulmonary arterial hypertension.
View activity & prices